Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Serum glomerular albumin permeability activity: association with rapid progression to end-stage renal disease in focal segmental glomerulosclerosis. Springerplus 2016;5:432

Date

04/23/2016

Pubmed ID

27104120

Pubmed Central ID

PMC4828406

DOI

10.1186/s40064-016-2077-9

Abstract

BACKGROUND: Focal segmental glomerulosclerosis (FSGS) is a major cause of renal failure. Sera of some FSGS patients increase glomerular albumin permeability (Palb) during in vitro testing and cause proteinuria in experimental animals.

OBJECTIVES: To determine whether permeability activity of FSGS serum (Palb activity) is associated with rate of progression to renal replacement therapy (RRT).

DESIGN: This is an observational study based on medical and demographic information and Palb activity testing.

SETTING: Studies were performed at Medical College of Wisconsin.

PATIENTS: Serum was submitted by patients' nephrologists for measurement of Palb activity. Each patient had had a biopsy diagnosis of FSGS, had reached ESRD and was on dialysis or had a functioning transplant.

MEASUREMENTS: Palb activity, clinical characteristics and time between biopsy diagnosis and RRT (T-RRT) were recorded for each patient.

METHODS: Palb activity was measured using established in vitro techniques.

RESULTS: Palb and T-RRT were inversely correlated. Neither Palb nor T-RRT varied with demographics or medications. Kaplan-Meier survival curves showed that patients with Palb ≥ 0.5 progressed to RRT more rapidly than others.

LIMITATIONS: Only patients who had reached RRT were included. Limited clinical information was available for each patient. Central verification of biopsy characteristics was not performed and detailed descriptions of renal histology were not available.

CONCLUSIONS: Palb activity is associated with the rate of progression to RRT in patients with FSGS. Additional observations will be needed to verify that Palb activity predicts prognosis and is useful in stratifying patients for clinical decision making or treatment trials.

Author List

Pudur S, Srivastava T, Sharma M, Sharma R, Tarima S, Dai H, McCarthy ET, Savin VJ

Author

Sergey S. Tarima PhD Associate Professor in the Institute for Health and Equity department at Medical College of Wisconsin




jenkins-FCD Prod-480 9a4deaf152b0b06dd18151814fff2e18f6c05280